About The Reproductive Times
Introducing a new media entity with limitless opportunities, exclusively dedicated to progress in reproductive sciences and reproductive medicine.
September 3, 2024
The Reproductive Times is a new medium established today by Norbert Gleicher, MD, a lifelong physician, scientist, author, and editor in reproductive medicine, and his team, with the goal of becoming a worldwide source for everything worth knowing in reproductive sciences and reproductive clinical medicine. Meant for a range of audiences in reproduction and reproductive health—interested lay public, basic research scientists, clinicians and embryologists (or “laboratory clinicians,” as we like to call them) —this medium will feature a diverse spread of materials for all interest groups, characterized by honesty, transparency, independence from commercial influences and, yes, at times outspokenness and fearlessness.
Articles may offer basic medical and/or scientific information, investigative stories, relevant worldwide news, an ongoing literature review and, of course, commentaries which at times are purposefully meant to be provocative. We expect to interview interesting guests and to offer their comments on camera as well as transcribed and will do the same with debates on controversial issues.
There is so much happening in the field every day that nobody knows about. Just informing readers about a small fraction of the unknown will make The Reproductive Times a successful endeavor. While you may not agree with everything we publish, we argue that this should be a reason to engage. Dissonance and disagreement drive progress and this is, after all, a common goal for everybody interested in reproduction.
We always look for outside contributors. To get in touch, please write to Hello@ReproductiveTimes.com.
If you are not already subscribed, follow the button below for a free subscription.
~ The Reproductive Times Team
Find our most recent postings below.
This week we discuss In our today’s posting, we offer quite critical reviews of recently published papers relating to two very important clinical subjects, Polycystic Ovary Syndrome (PCOS) and Clinical In Vitro Fertilization.
Both subjects, because of their importance and high prevalence, are frequently addressed in our Literature Review section. But only rarely have we had to make such critical comments about so many papers as in this posting, creating an unexpected problem:
From time to time we dislike a paper enough to award it the “Worst Paper Award” for the day. This time, we could have given out at least three to four such awards, were it not for the oxymoron that such a decision would create, considering it is the “worst” paper award, and that can be only one paper on a given day. Consequently, you will find today at least three additional papers which, on most other days, would have won the big prize and, this time, were very lucky to – just – have avoided the designation. But sometimes poor papers teach us more than good ones, and at least some of today’s poor papers do exactly that.
About our Founder:
Norbert Gleicher, MD, FACOG, FACS, is an infertility specialist with decades of clinical experience, widely considered one of the original IVF pioneers in the country who – among many other firsts- published the first vaginal egg retrieval under ultrasound control in the world, which changed IVF practice worldwide. He was also for 20 years the founding Editor-in-Chief of the Journal of In Vitro Fertilization and Embryo Transfer, two years later renamed the Journal of Assisted Reproduction and Genetics (JARG). He is also worldwide recognized as a leading reproductive immunologist, and, indeed, was the first Vice-President of the American Society for Reproductive Immunology and the founding Editor-in-Chief of its journal, The American Journal of Reproductive Immunology (AJRM).